Novo Nordisk
Pharma

UPDATE: Novo shares plummet on sales, profit warning for '26

Novo turned in sales and profit growth in 2025 amid an intense obesity market rivalry with Lilly. This year, the company is forecasting declines.
space launch rocketship

Top 10 most anticipated drug launches of 2026

Feb 2, 2026 3:00am
4x3png

Why Innovation Matters in First-Line HER2+ GEA

Feb 2, 2026 8:00am
Sunrise over foggy forest in Tuscany Italy

Sun Pharma brings skin cancer awareness to Super Bowl ‘SUNday’

Feb 5, 2026 8:00am
Why human expertise still matters in AI-driven med comms

Why human expertise still matters in AI-driven med comms

Feb 2, 2026 8:00am
Capitol Building and Congress

FDA’s rare pediatric voucher program revived by funding bill

Feb 4, 2026 3:12pm
More News

Lilly sees big sales increase in 2026 despite pricing pressures

Feb 4, 2026 2:55pm

AbbVie touts Skyrizi, Rinvoq prowess amid J&J IBD competition

Feb 4, 2026 2:52pm

Novartis CEO eyes 2026 growth despite record patent cliff

Feb 4, 2026 2:30pm
Fierce Healthcare

FTC, Express Scripts reach settlement in insulin pricing case

Feb 4, 2026 12:35pm